ALPS Medical Breakthroughs ETF (USD) (SBIO, US00162Q5936)

(%)

34,45 USD

NAV per azione

Exchange Traded Funds (ETF)

Tipologia di fondo

Equity

Oggetto d'investimento

Biotech

Settore

USA

Geografia

29/12/2014

Data di inizio

110,24 ml USD

Totale attivo del fondo

0.5 %

Rapporto costo totale

S-Network Medical Breakthroughs Index

Benchmark

ALPS Advisors

Provider

110,24 ml USD

Attività della classe azionaria

1 volte l'anno

Pagamento dei dividendi

Metodo di replica

Soglia minima di ingresso

Diviso

US00162Q5936

ISIN

SBIO

Ticker

CEOJMS

CFI

Utilizza il più completo database finanziario

800 000

obbligazioni

Oltre 400

fonti di prezzo

80 000

azioni

9 000

ETF

Monitora il tuo portafoglio nel modo più efficiente

bond screener

Watchlist

Excel ADD-IN

Ottieni l'accesso

Quote (SBIO)

Redditività su 03/05/2024

YTD

5,03 %
1M

0,25 %
3M

2,87 %
6M

31,97 %
1Y

11,15 %
3Y

-30,48 %
5Y

-0,39 %
10Y

-

Al prezzo di scambio, tenendo conto dei pagamenti di reddito

Dinamica dei prezzi

Struttura su 03/05/2024

Documento	Valore
Viking Therapeutics Inc.	5,13%
Cerevel Therapeutics Holdings Inc.	4,9%
Vaxcyte Inc.	4,52%
REVOLUTION Medicines Inc.	4,2%
Alpine Immune Sciences Inc.	2,69%
Alkermes PLC	2,55%
Crinetics Pharmaceuticals Inc.	2,33%
Axsome Therapeutics Inc.	2,25%
SpringWorks Therapeutics Inc.	2,11%
Xenon Pharmaceuticals Inc.	2,09%
Ideaya Biosciences Inc.	1,97%
Summit Therapeutics Inc.	1,96%
Immunocore Holdings PLC	1,9%
ACADIA Pharmaceuticals Inc.	1,78%
Merus NV	1,78%
Arcellx Inc.	1,77%
Celldex Therapeutics Inc.	1,74%
MoonLake Immunotherapeutics	1,72%
Rhythm Pharmaceuticals Inc.	1,67%
Corcept Therapeutics Inc.	1,61%
Vera Therapeutics Inc.	1,51%
Denali Therapeutics Inc.	1,51%
Vericel Corp.	1,47%
Intellia Therapeutics Inc.	1,44%
Arvinas Inc.	1,42%
Keros Therapeutics Inc.	1,38%
Geron Corp.	1,36%
Avidity Biosciences Inc.	1,34%
Deciphera Pharmaceuticals Inc.	1,3%
Agios Pharmaceuticals Inc.	1,23%
Galapagos NV	1,22%
Syndax Pharmaceuticals Inc.	1,19%
Edgewise Therapeutics Inc.	1,15%
Catalyst Pharmaceuticals Inc.	1,1%
Inhibrx Inc.	1,03%
Zai Lab Ltd.	1,02%
Kura Oncology Inc.	1%
Protagonist Therapeutics Inc.	0,97%
Day One Biopharmaceuticals Inc.	0,95%
Morphic Holding Inc.	0,95%
Xencor Inc.	0,94%
Arcus Biosciences Inc.	0,9%
Neumora Therapeutics Inc.	0,89%
Vir Biotechnology Inc.	0,89%
Tarsus Pharmaceuticals Inc.	0,88%
Soleno Therapeutics Inc.	0,87%
4D Molecular Therapeutics Inc.	0,83%
Ironwood Pharmaceuticals Inc.	0,81%
Verona Pharma PLC	0,8%
Prothena Corp. PLC	0,78%
Mirum Pharmaceuticals Inc.	0,76%
MannKind Corp.	0,75%
Akero Therapeutics Inc.	0,7%
MiMedx Group Inc.	0,69%
MacroGenics Inc.	0,62%
Liquidia Corp.	0,62%
Viridian Therapeutics Inc.	0,61%
ARS Pharmaceuticals Inc.	0,59%
OPKO Health Inc.	0,58%
BioCryst Pharmaceuticals Inc.	0,58%
89bio Inc.	0,55%
Pliant Therapeutics Inc.	0,53%
Zentalis Pharmaceuticals Inc.	0,53%
Kiniksa Pharmaceuticals Ltd.	0,51%
Aurinia Pharmaceuticals Inc.	0,47%
Arcturus Therapeutics Holdings Inc.	0,46%
Disc Medicine Inc.	0,46%
AnaptysBio Inc.	0,45%
Savara Inc.	0,4%
Olema Pharmaceuticals Inc.	0,37%
Aerovate Therapeutics Inc.	0,36%
Compass Pathways PLC	0,35%
Mineralys Therapeutics Inc.	0,34%
Allogene Therapeutics Inc.	0,33%
Alector Inc.	0,33%
Fulcrum Therapeutics Inc.	0,3%
Travere Therapeutics Inc.	0,3%
Biomea Fusion Inc.	0,28%
Replimune Group Inc.	0,27%
ACELYRIN Inc.	0,27%
iTeos Therapeutics Inc.	0,27%
Aura Biosciences Inc.	0,25%
Atea Pharmaceuticals Inc.	0,21%
Enanta Pharmaceuticals Inc.	0,2%
Anavex Life Sciences Corp.	0,2%
Inozyme Pharma Inc.	0,19%
RAPT Therapeutics Inc.	0,18%
Vanda Pharmaceuticals Inc.	0,18%
Amylyx Pharmaceuticals Inc.	0,09%
Reneo Pharmaceuticals Inc.	0,04%
Cash and Equivalents	0,03%
Chinook Therapeutics Inc.	0%
Radius Health CVR	0%
Azn Ln - Cvr	0%
AstraZeneca PLC	0%

Mostra di più Nascondi

Scarica la struttura in Excel